Drugs / TNF-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05898451 | Jun 2009 → Nov 2011 | cancer | Refnot-Pharm Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNF-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05898451 ↗ |
| Modality | Protein / enzyme biologic | “Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)” NCT05898451 ↗ |